Faecal microbiota transplantation for severe clostridium difficile infection in the intensive care unit
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We describe a case of faecal microbiota transplantation (FMT) used for severe binary toxin-positive Clostridium difficile infection in an intensive care setting. The patient was admitted to the ICU of a tertiary hospital and failed traditional maximal pharmacological management. Adjunctive therapy with FMT given through gastroscopy resulted in resolution of the C. difficile-related symptoms. Although there is a growing experience with FMT for recurrent C. difficile infection, published evidence in severe disease is very limited. In a landscape of increasingly severe C. difficile infection, adjunctive FMT may be considered a useful early treatment option.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however a few case reports suggest that it may be safe and effective even in critically ill patients18–21.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [20]
Citations
Cites
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
(1958) · PubMed · Cited by 978
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649
Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., Garcia, R. J., Brandmarker, S., Bowen, K., Borjal, D., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/318130 · Cited by 529
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
The outcome of surgery in fulminant Clostridium difficile colitis
Koss, K., Clark, M. A., Sanders, D. S. A., Morton, D., Keighley, M. R. B., & Goh, J. (2006) · Colorectal Disease · doi:10.1111/j.1463-1318.2005.00876.x · Cited by 184
Yoon, S. S., & Brandt, L. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181dac035 · Cited by 178
Herpers, B. L., Vlaminckx, B., Burkhardt, O., Blom, H., Biemond‐Moeniralam, H. S., Hornef, M., Welte, T., & Kuijper, E. J. (2009) · Clinical Infectious Diseases · doi:10.1086/599224 · Cited by 164
Research works printed but not linked: 3
- Brandt, 2011, First-Line treatment for severe Clostridium difficile infection J Clin Gastroenterol, 45, 655
- Eiseman, 1958, Surgery, 44, 854
- Gallegos-Orozco, 2012, Rev Gastroenterol Mex, 77, 40
Cited by
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
Therapeutic Potential of Fecal Microbiota Transplantation
Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J., & Nieuwdorp, M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.058 · Cited by 717
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly, C. R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., & Wu, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.008 · Cited by 572
Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428
“Rubin et al31 USA 74 63 (6-94) Recurrent (2 or more) Stomach/ nasogastric tube 64) Percutaneous gastrostomy tube (4) Upper endoscopy (7) 30/50-70 59/57 12wk O: M-V”
BackgroundInfluentialSystematic Review: Adverse Events of Fecal Microbiota Transplantation
Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., & Wang, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161174 · Cited by 409
“) Definitely related to FMT Probably related to FMT Possibly related to FMT Unrelated to FMT Mellow, 2011 [77] CDI relapse Death from pneumonia; Death from superior mesenteric vein thrombosis; Death from ovarian cancer Aas, 2003 [62] Death from peritonitis Death from pneumonia Mandalia, 2014 [78] Diverticulitis; Fever…”
Adverse events in faecal microbiota transplant: a review of the literature
Baxter, M., & Colville, A. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.10.024 · Cited by 185
Sha, S., Liang, J., Chen, M., Xu, B., Liang, C., Wei, N., & Wu, K. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12699 · Cited by 134
Consensus report: faecal microbiota transfer – clinical applications and procedures
König, J., Siebenhaar, A., Högenauer, C., Arkkila, P., Nieuwdorp, M., Norén, T., Ponsioen, C. Y., Rosien, U., Rossen, N. G., Satokari, R., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13868 · Cited by 114
Trubiano, J. A., Cheng, A. C., Korman, T. M., Röder, C., Campbell, A. J., May, M., Blyth, C. C., Ferguson, J., Blackmore, T., Riley, T. V., et al. (2016) · Internal Medicine Journal · doi:10.1111/imj.13027 · Cited by 128
Clostridium difficile infection: a review of current and emerging therapies
Ofosu, A. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0006 · Cited by 127
Clostridioides difficile: diagnosis and treatments
Guery, B., Galperine, T., & Barbut, F. (2019) · BMJ · doi:10.1136/bmj.l4609 · Cited by 106
Ramai, D. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0328 · Cited by 93
“Common upper gastrointestinal routes include esophagogastroduodenoscopy via enteric tubes (nasogastric, nasoduodenal, and nasojejunal tubes), and oral capsules [32,52,61-64].”
BackgroundRecurrent Clostridium difficile infection: From colonization to cure
Shields, K., Araujo-Castillo, R. V., Theethira, T. G., Alonso, C. D., & Kelly, C. P. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.04.012 · Cited by 93
Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection
Rao, K. K., & Young, V. B. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.009 · Cited by 87
Zainah, H., Hassan, M. M., Sroujieh, L., Hassan, S., Alangaden, G. J., & Ramesh, M. S. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3296-y · Cited by 87
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
Rao, K., & Safdar, N. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2449 · Cited by 70
Rao, K. K., & Higgins, P. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000793 · Cited by 59
Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review
Chapman, B. C., Moore, H. B., Overbey, D. M., Morton, A. P., Harnke, B., Gerich, M. E., & Vogel, J. D. (2016) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0000000000001195 · Cited by 51
Khoruts, A., & Weingarden, A. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.07.016 · Cited by 47
Potential relevance of pig gut content transplantation for production and research
Canibe, N., O’Dea, M. A., & Abraham, S. (2019) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-019-0363-4 · Cited by 51
Khan, R., Roy, N., Ali, H., & Naeem, M. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/9999925 · Cited by 42
van Beurden, Y. H., Nieuwdorp, M., van de Berg, P. J. E. J., Mulder, C. J. J., & Goorhuis, A. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17690480 · Cited by 36
“In three patients, antibiotic CDI therapy was continued after FMT [Trubiano et al. 2013; Pecere et al. 2015; Jeon et al. 2016].”
BackgroundFecal microbiota transplantation for recurrent Clostridioides difficile , safety, and pitfalls
Sandhu, A., & Chopra, T. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211053105 · Cited by 41
Rao, K. K., Santhosh, K., Mogle, J. A., Higgins, P., & Young, V. B. (2016) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2016.1186832 · Cited by 35
Host Immunity and Immunization Strategies for Clostridioides difficile Infection
Naz, F., & Petri, W. A. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00157-22 · Cited by 28
Fecal Microbial Transplantation in Critically Ill Patients—Structured Review and Perspectives
Cibulková, I., Řehořová, V., Hajer, J., & Duška, F. (2021) · Biomolecules · doi:10.3390/biom11101459 · Cited by 30
“[60] 1/0 sCDI 75 1F Ug-Njt 1 × 1 pt R/Fresh ↓ D, ↓ Ilf x/no comment”
Han, S. S., Shannahan, S. E., & Pellish, R. S. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066615594344 · Cited by 34
“If the patient is stable enough to endure endoscopy, FMT via EGD-placed NJ or ND tube may be the safest method, as it does not risk colonic perforation, as reported by Trubiano et al in the ICU setting.(102) Weingarden et al, however, did safely utilize colonoscopy for FMT in a single patient on vasopressor and ventil…”
MethodDiagnosis and Management of Clostridium difficile Infection
Korman, T. M. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398741 · Cited by 34
The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series
Akamine, C. M., Ing, M. B., Jackson, C. S., & Loo, L. K. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1657-1 · Cited by 25
“The current data on FMT for the treatment of severe CDI is limited only to case reports or small case series [28, 29].”
BackgroundMonday, L., Tillotson, G., & Chopra, T. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s419243 · Cited by 25
Yu, S., Abdelkarim, A., Nawras, A. T., Hinch, B. T., Mbaso, C., Valavoor, S., Safi, F. A., Hammersley, J. R., Tang, J.-L., & Assaly, R. (2014) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000062 · Cited by 23
“Limited observational reports showed that fecal transplant can be used to treat severe C diff colitis successfully.(35,36) As per fecal transplant guidelines published in 2011, severe (and perhaps even fulminant) C diff colitis with no response to standard therapy after 48 hours is an indication for fecal transplant t…”
BackgroundMicrobiome: what intensivists should know
Nakov, R., Segal, J. P., Settanni, C. R., Bibbò, S., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14278-0 · Cited by 23
Trubiano, J. A., George, A., Barnett, J., Siwan, M., Heriot, A. G., Prince, H. M., Slavin, M. A., & Teh, B. W. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.920503 · Cited by 15
Trasplante de microbiota fecal
de Paredes, A. G. G., de Santiago, E. R., Aguilera, L., Ferre‐Aracil, C., & López–Sanromán, A. (2014) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2014.07.010 · Cited by 29
Kump, P. K., & Högenauer, C. (2016) · Digestive Diseases · doi:10.1159/000447379 · Cited by 14
Clostridium difficile: biological therapies
Martin, J. S. H., Mawer, D. P. C., & Wilcox, M. H. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000433319.82618.8f · Cited by 13
“[55] describes a FMT performed for severe disease in an intensive care unit.”
Therapy for Clostridium difficile infection – any news beyond Metronidazole and Vancomycin?
Manthey, C. F., Eckmann, L., & Fuhrmann, V. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1362978 · Cited by 16
“although case reports support the safety and feasibility of FMT in these patients [71].”
BackgroundResultDysbiosis and Gut Microbiota Modulation in Systemic Sclerosis
Lemos, M. P. C., Zucoloto, T. G., Oliveira, M. C., & de Oliveira, G. L. V. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001748 · Cited by 12
The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies
Tourelle, K. M., Boutin, S., Weigand, M. A., & Schmitt, F. C. F. (2021) · Biomedicines · doi:10.3390/biomedicines9101305 · Cited by 11
Le transfert de flore digestive : une revue de la littérature
Barbut, F., Collignon, A., Butel, M. J., & Bourlioux, P. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2014.05.004 · Cited by 12
Berro, Z., Hamdan, R., Dandache, I., Saab, M., Karnib, H. H., & Younes, M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1571-6 · Cited by 9
“Several published cases from USA [17–19], Canada [20], United kingdom [21], China [22–24], Korea [25], Germany [26], Switzerland [27], Hungary [28], Italy [29], Denmark [30], Sweden [31], Norway [32], Romania [33], Finland [34], Australia [9, 35] and Czech Republic [36] have described performing FMT and getting good c…”
BackgroundTherapeutic Potential of the Human Gastrointestinal Microbiome
Borody, T. J., Peattie, D. A., & Campbell, J. (2013) · Drug Development Research · doi:10.1002/ddr.21093 · Cited by 8
“Reconstituting the gut microbial ecology with FMT, thereby re-establishing the wide diversity of intestinal microbiota, has shown promise in severe CDI patients [Trubiano et al., 2012; Weingarden et al., 2013] and provides rapid clinical cure in R-CDI patients [Borody and Khoruts, 2012].”
BackgroundDiagnostic and therapy of severe Clostridioides difficile infections in the ICU
Guery, B. P., Barbut, F., & Tschudin‐Sutter, S. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000753 · Cited by 7
The gut microbiome takes center stage in critical care
Wiersinga, W. J. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000390 · Cited by 4
Řehořová, V., Cibulková, I., Soukupova, H., & Duška, F. (2022) · Future Pharmacology · doi:10.3390/futurepharmacol2010005 · Cited by 4
Sharma, S., Gilberto, V. S., Levens, C. L., Chatterjee, A., Kuhn, K. A., & Nagpal, P. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00102 · Cited by 4
Gîlcă-Blanariu, G.-E., Ștefănescu, G., Gîrleanu, I., Iqbal, T. H., Segal, J. P., Mullish, B. H., Quraishi, M. N., Keller, J. J., Molnár, T., Mégraud, F., et al. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3297 · Cited by 6
“In principle, donors genetically related to FMT recipients showed similarities in their intestinal microbiota [94], because donors and recipients living in the same house are largely exposed to the same infectious risk factors and allergens [95].”
BackgroundFecal microbiota transplantation: Safe, simple, and effective
Stawicki, S. P., Smith, E., Duarte-Chavez, R., Samia, H., Knight, P., Tolentino, J. C., Wojda, T., Cornejo, K. M., Siciliano, M., & Geme, B. M. (2018) · International Journal of Academic Medicine · doi:10.4103/ijam.ijam_33_18 · Cited by 4
Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015
Carmo, J., Marques, S., Chapim, I., Túlio, M. A., Rodrigues, J. P., Bispo, M., & Chagas, C. (2015) · GE Portuguese Journal of Gastroenterology · doi:10.1016/j.jpge.2015.07.006 · Cited by 7
Halabi, J. E., Palmer, N., Fox, K. P., Kohane, I. S., & Farhat, M. R. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01822-y · Cited by 3
Kates, A., Tischendorf, J. S., Schweizer, M. L., Herwaldt, L. A., Samore, M. H., Dukes, K., Gerding, D. N., Diekema, D. J., & Safdar, N. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.311 · Cited by 4
Beyond Penicillin: Rapid Desensitization for Specific Flucloxacillin Hypersensitivity
Kwong, J. C., Urbancic, K. F., & Trubiano, J. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01371-18 · Cited by 3
“Although some historical approaches involving penicillin desensitization followed by full-dose oxacillin therapy may be successful for patients with general penicillin allergies (6), in which the antigen is the major (benzylpenicilloyl-poly-L-lysine) or minor (benzylpenicillin, sodium benzylpenilloic acid, or benzylpe…”
BackgroundBozkurt, H. S., & Kara, B. (2019) · SAGE Open Medical Case Reports · doi:10.1177/2050313x19838442 · Cited by 2
Fecal microbiota transplantation in a patient hospitalized in the intensive care unit – Case report
Oliwa-Libumska, K., Jaworska-Czerwińska, A., Małłek-Grabowska, M., Wlodarski, R., Żuratyński, P., & Kozłowski, B. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42793 · Cited by 3
“An alternative method in the fight against CDI is fecal microbiota transplantation – FMT [4,7-9, 11, 13-19 13-19 ].”
Faecal microbiota transplantation for refractory C lostridium difficile infection
Tamilarasan, A. G., Irving, P. M., Meadows, C. I. S., & Goldenberg, S. D. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-231027 · Cited by 2
Comment traiter une infection digestive à Clostridium difficile en 2014 ?
Barbut, F., Guery, B. P., & Eckert, C. (2014) · Réanimation · doi:10.1007/s13546-014-0867-z · Cited by 1
Fecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspective
Borody, T. J., & Finlayson, S. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.013 · Cited by 1
Fecal Microbiota Transplantation: A Novel Way to Treat Gastrointestinal Disorders
Horowitz, S. (2013) · Alternative and Complementary Therapies · doi:10.1089/act.2013.19202 · Cited by 1
Sharma, S., Gilberto, V. S., Levens, C. L., Chatterjee, A., Kuhn, K. A., & Nagpal, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.20.581256 · Cited by 1
Blanco, D. A., & Pall, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00057-8
Jin, C., Hu, Y. C., & Jin, B. (2020) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v28.i4.135
Κακαρούμπα, Ν. (2011) · Νημερτής · Cited by 1
Kobeissy, H. (2018) · theses.fr (ABES) · doi:10.70675/f14d613cz28dfz470aza7a6zdbe81a631560 · Cited by 1
Metadata
- Authors
- Trubiano, J. A., Gardiner, B., Kwong, J. C., Ward, P., Testro, A. G., & Charles, P. G. P.
- Affiliations
- Austin Hospital (AU)
- Austin Health (AU)
- The University of Melbourne (AU)
- Corresponding author
- Trubiano, Jason A.
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2013-02
- Volume
- 25
- Issue
- 2
- Pages
- 255-257
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2324833893
- Cited by
- 64
- References
- 15
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 4 · 2016: 10 · 2015: 8 · 2014: 10 · 2013: 4
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, Clostridium difficile infection, serious infections, intensive care unit, adjunctive therapy, recurrent Clostridium difficile infection
- MeSH terms
- Aged, Combined Modality Therapy, Critical Care, Enterocolitis, Pseudomembranous, Feces, Female, Gastroscopy, Humans, Clostridioides difficile, Fatal Outcome, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.